Single-Cell Genomics in AML, Extending the Frontiers of AML Research

Ravi Majeti is a professor of medicine in the Division of Hematology at Stanford University. He's also the director of the Institute for Stem Cell Biology and Regenerative Medicine. Majeti: "We can learn a lot about the disease processes, both pathogenesis, disease monitoring, response to therapeutics, and potential novel areas"